Biology of Langerhans Cells and Langerhans Cell Histiocytosis

International Review of Cytology

Volumn 254, Issue , 2006, Pages 1-43

  Bechan, G I ^a,b   Egeler, R M ^a   Arceci, R J ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bystander cells; Cytokines; Langerhans cell; Langerhans cell histiocytosis; Langerhans cell histiocytosis cell

Indexed keywords

ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; CYTOKINE; DECTIN 1; FC RECEPTOR; GAMMA INTERFERON RECEPTOR; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HERMES ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6 RECEPTOR; LECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SPHINGOSINE 1 PHOSPHATE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANTIGEN EXPRESSION; BYSTANDER EFFECT; CELL INTERACTION; CELL LINEAGE; CELL MATURATION; CELL TYPE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLONAL VARIATION; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHIL; FIBROBLAST; GENE MUTATION; GIANT CELL; HETEROZYGOSITY LOSS; HISTIOCYTOSIS X; HUMAN; IMMUNOPHENOTYPING; LANGERHANS CELL; MACROPHAGE; MUTATIONAL ANALYSIS; NATURAL KILLER CELL; ONTOGENY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROMA CELL; SYSTEMIC THERAPY; T LYMPHOCYTE; TISSUE INJURY; X CHROMOSOME INACTIVATION;

ANIMALS; CHEMOKINES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LANGERHANS CELLS;

EID: 35548966933     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(06)54001-X     Document Type: Review

References (252)

1. Abdelatif O.M., Chandler F.W., Pantazis C.G., and McGuire B.S. Enhanced expression of c-myc and H-ras oncogenes in Letterer-Siwe disease. A sequential study using colorimetric in situ hybridization. Arch. Pathol. Lab. Med. 114 (1990) 1254-1260
2. Aggarwal B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
3. Amft N., Curnow S.J., Scheel-Toellner D., Devadas A., Oates J., Crocker J., Hamburger J., Ainsworth J., Mathews J., Salmon M., Bowman S.J., and Buckley C.D. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arth. Rheum. 44 (2001) 2633-2641
4. Anderson J.M. Multinucleated giant cells. Curr. Opin. Hematol. 7 (2000) 40-47
5. Andersson By U., Tani E., Andersson U., and Henter J.I. Tumor necrosis factor, interleukin 11, and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 26 (2004) 706-711
6. Anjuere F., del Hoyo G.M., Martin P., and Ardavin C. Langerhans cells develop from a lymphoid-committed precursor. Blood 96 (2000) 1633-1637
7. Anjuere F., Martin P., Ferrero I., et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes and skin of the mouse. Blood 93 (1999) 590-593
8. Annels N.E., Da Costa C.E., Prins F.A., Willemze A., Hogendoorn P.C., and Egeler R.M. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J. Exp. Med. 197 (2003) 1385-1390
9. Arceci R.J., Longley B.J., and Emanuel P.D. Atypical cellular disorders. Hematology Am. Soc. Hematol. Educ. Program (2002) 297-314
10. Ardavin C., Martinez del Hoyo G., Martin P., Anjuere F., Arias C.F., Marin A.R., Ruiz S., Parrillas V., and Hernandez H. Origin and differentiation of dendritic cells. Trends Immunol. 22 (2001) 691-700
11. Ardavin C., Wu L., Li C.L., and Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362 (1993) 761-763
12. Arenzana-Seisdedos F., Barbey S., Virelizier J.L., Kornprobst M., and Nezelof C. Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J. Clin. Invest. 77 (1986) 326-329
13. Arico M. Langerhans cell histiocytosis in adults: More questions than answers?. Eur. J. Cancer 40 (2004) 1467-1473
14. Arico M., Nichols K., Whitlock J.A., Arceci R.J., Haupt R., Mittler U., Kuhne T., Lombardi A., Ishii E., Egeler R.M., and Danesino C. Familial clustering of Langerhans cell histiocytosis. Br. J. Haematol. 107 (1999) 883-888
15. Ariizumi K., Shen G.L., Shikano S., Xu S., Ritter III R., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., and Takashima A. Identification of a Novel, Dendritic Cell-associated Molecule, Dectin-1, by Subtractive cDNA Cloning. J. Biol. Chem. 275 (2000) 20157-20167
16. Armengol M.-P., Cardoso-Schmidt C.B., Fernández M., Ferrer X., Pujol-Borrell R., and Juan M. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170 (2003) 6320-6328
17. Armitage R.J., Fanslow W.C., Strockbine L., Sato T.A., Clifford K.N., Macduff B.M., Anderson D.M., Gimpel S.D., Davis-Smith T., Maliszewski C.R., et al. Molecular and biological characterization of a murine ligand for CD40. Nature 357 (1992) 80-82
18. Austyn J.M. Dendritic cells. Curr. Opin. Hematol. 5 (1998) 3-15
19. Baba M., Imai T., Nishimura M., Kakizaki M., Takagi S., Hieshima K., Nomiyama H., and Yoshie O. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 272 (1997) 14893-14898
20. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
21. Bank M.I., Gudbrand C., Rengtved P., Carstensen H., Fadeel B., Henter J.I., and Petersen B.L. Immunohistochemical detection of the apoptosis-related proteins FADD, FLICE, and FLIP in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 27 (2005) 301-306
22. Bank M.I., Rengtved P., Carstensen H., and Petersen B.L. p53 expression in biopsies from children with Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24 (2002) 733-736
23. Bank M.I., Rengtved P., Carstensen H., and Petersen B.L. Langerhans cell histiocytosis: An evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 111 (2003) 300-308
24. Bauer J., Bahmer F.A., Worl J., Neuhuber W., Schuler G., and Fartasch M. A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical dissector method and the confocal laser scanning microscope. J. Invest. Dermatol. 116 (2001) 313-318
25. Berthier-Vergnes O., Bermond F., Flacher V., Massacrier C., Schmitt D., and Peguet-Navarro J. TNF-alpha enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production. FEBS Lett. 579 (2005) 3660-3668
26. Betts D.R., Leibundgut K.E., Feldges A., Pluss H.J., and Niggli F.K. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br. J. Cancer 77 (1998) 552-555
27. Bieber T., Rieger A., Neuchrist C., Prinz J.C., Rieber E.P., Boltz-Nitulescu G., Scheiner O., Kraft D., Ring J., and Stingl G. Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J. Exp. Med. 170 (1989) 309-314
28. Birbeck M.S., Breatnach A.S., and Everall J.D. An electron microscopic study of basal melanocytes and high level clear cells (Langerhans cell) in vitiligo. J. Invest. Dermatol. 37 (1961) 51-64
29. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9 (1997) 24-34
30. Bjorck P., Banchereau J., and Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 9 (1997) 365-372
31. Bockman R.S., and Repo M.A. Lymphokine-mediated bone resorption requires endogenous prostaglandin synthesis. J. Exp. Med. 154 (1981) 529-534
32. Border W.A., and Noble N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331 (1994) 1286-1292
33. Borkowski T.A., Letterio J.J., Farr A.G., and Udey M.C. A role for endogenous transforming growth factor 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184 (1996) 2417-2422
34. Borkowski T.A., Letterio J.J., Mackall C.L., Saitoh A., Wang X.J., Roop D.R., Gress R.E., and Udey M.C. A role for TGFbeta1 in Langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J. Clin. Invest. 100 (1997) 575-581
35. Borkowski T.A., Letterio J.J., Mackall C.L., Saitoh A., Farr A.G., Wang X.J., Roop D.R., Gress R.E., and Udey M.C. Langerhans cells in the TGF beta 1 null mouse. Adv. Exp. Med. Biol. 417 (1997) 307-310
36. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P., and Michel F.B. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323 (1990) 1033 -1039
37. Brouty-Boyé D., Pottin-Clémenceau C., Doucet C., Jasmin C., and Azzarone B. Chemokines and CD40 expression in human fibroblasts. Eur. J. Immunol. 30 (2000) 914-919
38. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., and Gordon S. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197 (2003) 1119-1124
39. Buckley C. Why does chronic inflammatory joint disease persist?. Clin. Med. 3 (2003) 361-366
40. Buckley C.D., Pilling D., Lord J.M., Akbar A.N., Scheel-Toellner D., and Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22 (2001) 199-204
41. Cantin A.M., Boileau R., and Begin R. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lung of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 137 (1988) 572-578
42. Carstensen H., and Ornvold K. The epidemiology of LCH in children in Denmark, 1975-89. Med. Pediatr. Oncol. 21 (1993) 387-388
43. Caux C., Dezutter-Dambuyant C., Schmitt D., and Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360 (1992) 258-261
44. Caux C., Massacrier C., Dubois B., Valladeau J., Dezutter-Dambuyant C., Durand I., Schmitt D., and Saeland S. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J. Leukoc. Biol. 66 (1999) 781-791
45. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., and Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180 (1994) 1263-1272
46. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., and Banchereau J. CD34+ Hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFalpha. J. Exp. Med. 184 (1996) 695-706
47. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184 (1996) 747-752
48. Chang H.Y., Chi J.T., Dudoit S., Bondre C., van de Rijn M., Botstein D., and Brown P.O. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. USA 99 (2002) 12877-12882
49. Chang-Rodriguez S., Ecker R., Stingl G., and Elbe-Burger A. Autocrine IL-10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells. J. Leukoc. Biol. 76 (2004) 657-666
50. Chang-Rodriguez S., Hoetzenecker W., Schwarzler C., Biedermann T., Saeland S., and Elbe-Burger A. Fetal and neonatal murine skin harbors Langerhans cell precursors. J. Leukoc. Biol. 77 (2005) 352-360
51. Chu T., D'Angio G.J., Favara B.E., Ladisch S., Nesbit M., and Pritchard J. Histiocytosis syndromes in children. Lancet 2 (1987) 41-42
52. Coppes-Zantinga A., and Egeler R.M. The Langerhans cell histiocytosis X files revealed. Br. J. Haematol. 116 (2002) 3-9
53. Cumberbatch M., Bhushan M., Dearman R.J., Kimber I., and Griffiths C.E. IL-1-induced Langerhans' cell migration and TNF- production in human skin: Regulation by lactoferrin. Clin. Exp. Immunol. 132 (2003) 352-359
54. Cumberbatch M., Dearman R.J., Griffiths C.E.M., and Kimber I. Langerhans cell migration. Clin. Exp. Dermatol. 25 (2000) 413-418
55. Cumberbatch M., Griffiths C.E., Tucker S.C., Dearman R.J., and Kimber I. Tumour necrosis factor-induces Langerhans cell migration in humans. Br. J. Dermatol. 141 (1999) 192-200
56. Czernielewski J., and Demarchez M. Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J. Invest. Dermatol. 88 (1987) 17-20
57. Czernielewski J., Vaigot P., and Prunieras M. Epidermal Langerhans cell-a cycling cell population. J. Invest. Dermatol. 84 (1985) 424-426
58. da Costa C.E., Annels N.E., Faaij C.M., Forsyth R.G., Hogendoorn P.C., and Egeler R.M. Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J. Exp. Med. 201 (2005) 687-693
59. Dacic S., Trusky C., Bakker A., Finkelstein S.D., and Yousem S.A. Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum. Pathol. 34 (2003) 1345-1349
60. Daugherty B.L., Siciliano S.J., DeMartino J.A., Malkowitz L., Sirotina A., and Springer M.S. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183 (1996) 2349-2354
61. Davis A.L., McKenzie J.L., and Hart D.N. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells. Immunology 65 (1988) 573-581
62. De Fraissinette A., Staquet M.J., Dezutter-Dambuyant C., Schmitt D., and Thivolet J. Langerhans cells in S-phase in normal skin detected by simultaneous analysis of cell surface antigen and BrdU incorporation. J. Invest. Dermatol. 91 (1988) 603-605
63. de Graaf J.H., Tamminga R.Y., Dam-Meiring A., Kamps W.A., and Timens W. The presence of cytokines in Langerhans' cell histiocytosis. J. Pathol. 180 (1996) 400-406
64. de Graaf J.H., Tamminga R.Y., Kamps W.A., and Timens W. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. Am. J. Pathol. 147 (1995) 1161-1171
65. Della Chiesa M., Sivori S., Castriconi R., Marcenaro E., and Moretta A. Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol. 13 (2005) 128-136
66. Della Chiesa M., Vitale M., Carlomagno S., Ferlazzo G., Moretta L., and Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33 (2003) 1657-1666
67. Dewar A.L., Doherty K.V., Woods G.M., Lyons A.B., and Muller H.K. Acquisition of immune function during the development of the Langerhans cell network in neonatal mice. Immunology 103 (2001) 61-69
68. Dieu-Nosjean M.C., Massacrier C., Homey B., Vanbervliet B., Pin J.J., Vicari A., Lebecque S., Dezutter-Dambuyant C., Schmitt D., Zlotnik A., and Caux C. Macrophage inflammatory protein 3 is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192 (2000) 705-718
69. Dieu-Nosjean M.C., Vicari A., Lebecque S., and Caux C. Regulation of dendritic cell trafficking: A process that involves the participation of selective chemokines. J. Leukoc. Biol. 66 (1999) 252-262
70. Duijvestijn A.M., and Kamperdijk E.W.A. Birbeck granules in interdigitating cells of thymus and lymph node. Cell Bio. Int. Rep. 6 (1982) 655
71. Ebner S., Ehammer Z., Holzmann S., Schwingshackl P., Forstner M., Stoitzner P., Huemer G.M., Fritsch P., and Romani N. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Intl. Immunol. 16 (2004) 877-887
72. Egeler R.M., Favara B.E., Laman J.D., and Claassen E. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur. J. Cancer. 36 (2000) 2105-2110
73. Egeler R.M., Favara B.E., van Meurs M., Laman J.D., and Claassen E. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood 94 (1999) 4195-4201
74. Elbe A., Tschachler E., Steiner G., Binder A., Wolff K., and Stingl G. Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period. J. Immunol. 143 (1989) 2431-2438
75. Elder J.T., Reynolds N.J., Cooper K.D., Griffiths C.E., Hardas B.D., and Bleicher P.A. CD1 gene expression in human skin. J. Dermat. Sci. 6 (1993) 206-213
76. Elsner J., Escher S.E., and Forssmann U. Chemokine receptor antagonists: A novel approach in allergic diseases. Allergy 59 (2004) 1243-1258
77. Elsner J., Hochstetter R., Kimmig D., and Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur. J. Immunol. 26 (1996) 1919-1925
78. Elsner J., Kapp A., Virchow Jr. J.C., and Luttmann W. Eosinophils: Quo vadis? The role of eosinophils in the chemokine network of allergy. Mod. Asp. Immunobiol. 2 (2001) 18-24
79. Emile J.-F., Fraitag S., Andry P., Leborgne M., Lellouch-Tubiana A., and Brousse N. Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells. Virchows Arch. 427 (1995) 125-129
80. Emile J.-F., Fraitag S., Leborgne M., de Prost Y., and Brousse N. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J. Pathol. 174 (1994) 71-76
81. Enk A.H., Angeloni V.L., Udey M.C., and Katz S.I. An essential role for Langerhans cell-derived-IL-1beta in the initiation of primary immune responses in the skin. J. Immunol. 150 (1993) 3698-3704
82. Enk A.H., and Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 89 (1992) 1398-1402
83. Fais S., Burgio V.L., Silvestri M., Capobianchi M.R., Pacchiarotti A., and Pallone F. Multinucleated giant cells generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophages fusion and multinucleated giant cell formation. Lab. Invest. 71 (1994) 737-744
84. Favara B.E., and Steele A. Langerhans cell histiocytosis of lymph nodes: A morphological assessment of 43 biopsies. Pediatr. Pathol. Lab. Med. 17 (1997) 769-787
85. Ferlazzo G., Semino S., and Melioli G. HLA Class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 76 (2001) 37-41
86. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., and Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195 (2002) 343-351
87. Fithian E., Kung P., Goldstein G., Rubenfeld M., Fenoglio C., and Edelson R. Reactivity of Langerhans cells with hybridoma antibody. Proc. Natl. Acad. Sci. USA 78 (1981) 2541-2544
88. Fleming M.D., Pinkus J.L., Fournier M.V., Alexander S.W., Tam C., Loda M., Sallan S.E., Nichols K.E., Carpentieri D.F., Pinkus G.S., and Rollins B.J. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood (2003)
89. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., Cumano A., and Geissmann F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311 (2006) 83-87
90. Fokkens W.J., Broekhuis-Fluitsma D.M., Rijntjes E., Vroom T.M., and Hoefsmit E.C.M. Langerhans cells in nasal mucosa of patients with grass pollen allergy. Immunobiology 182 (1991) 135-142
91. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., and Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
92. Galustian C., Park C.G., Chai W., Kiso M., Bruening S.A., Kang Y.S., Steinman R.M., and Feizi T. High and low affinity carbohydrate ligands revealed for murine SIGN- R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and Langerin. Int. Immunol. 16 (2004) 853-866
93. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
94. Gatti E., Velleca M.A., Biedermann B.C., Ma W., Unternaehrer J., Ebersold M.W., Medzhitov R., Pober J.S., and Mellman I. large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J. Immunol. 164 (2000) 3600-3607
95. Gavino A.C., Chung J.S., Sato K., Ariizumi K., and Cruz P.D.J. Identification and expression profiling of a human C-type lectin, structurally homologous to mouse dectin-2. Exp. Dermatol. 14 (2005) 281-288
96. Geissmann F., Lepelletier Y., Fraitag S., Valladeau J., Bodemer C., Debre M., Leborgne M., Saeland S., and Brousse N. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97 (2001) 1241-1248
97. Geissmann F., Prost C., Monnet J.P., Dy M., Brousse N., and Hermine O. Transforming growth factor 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187 (1998) 961-966
98. Girolomoni G., Caux C., Lebecque S., Dezutter-Dambuyant C., and Ricciardi-Castagnol P. Langerhans cells: Still a fundamental paradigm for studying the immunobiology of dendritic cells. Trends Immunol. 23 (2002) 6-8
99. Goodell A.L., Oh H.S., Meyer A., and Smart R.C. Epidermal protein kinase C-2 is highly sensitive to downregulation and is exclusively expressed in Langerhans cells: Downregulation is associated with attenuated contact hypersensitivity. J. Invest. Dermatol. 107 (1996) 354-359
100. Gowen M., Wood D.D., Ihrie E.J., McGuire M.K., and Russell R.G. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306 (1983) 378-380
101. Green E.A., and Flavell R.A. The temporal importance of TNFa expression in the development of diabetes. Immunity 12 (2000) 459-469
102. Grewal I.S., and Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16 (1998) 111-135
103. Groves R.W., Allen M.H., Ross E.L., Barker J.N., and MacDonald D.M. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132 (1995) 345-352
104. Grunebach F., Weck M.M., Reichert J., and Brossart P. Molecular and functional characterization of human Dectin-1. Exp. Hematol. 30 (2002) 1309-1315
105. Hage C., Willman C.L., Favara B.E., and Isaacson P.G. Langerhans' cell histiocytosis (histiocytosis X): Immunophenotype and growth fraction. Hum. Pathol. 24 (1993) 840-845
106. Halliday G.M., and Lucas A.D. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis. Immunology 79 (1993) 621-626
107. Hanau D., Fabre M., Schmitt D.A., Garaud J.C., Pauly G., Tongio M.M., Mayer S., and Cazenave J.P. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Proc. Natl. Acad. Sci. USA 84 (1987) 2901-2905
108. Heath H., Qin S., Rao P., LaRosa G., Kassam N., Ponath D., and Mackay C.R. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99 (1997) 178-184
109. Hernandez-Pando R., Bornstein Q.L., Aguilar Leon D., Orozco E.H., Madrigal V.K., and Martinez Cordero E. Inflammatory cytokine production by immunological and foreign body multinucleated giant cells. Immunology 100 (2000) 352-358
110. Herre J., Gordon S., and Brown G.D. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol. Immunol. 40 (2004) 869-876
111. Hjelmström P. Lymphoid neogenesis: De novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 69 (2001) 331-339
112. Holldack J., Burdach S., Eisberg A., Frisch J., and Schulz G. Biology and pharmacology of hematopoietic growth factors. Med. Pediatr. Oncol. Suppl. 2 (1992) 2-9
113. Hoshino T., Kukita A., and Sato S. Cells containing Birbeck granules (Langerhans cell granules) in the human thymus. J. Electron Microsc. 19 (1970) 271-276
114. Hunger R.E., Sieling P.A., Ochoa M.T., Sugaya M., Burdick A.E., Rea T.H., Brennan P.J., Belisle J.T., Blauvelt A., Porcelli S.A., and Modlin R.L. Langerhans cells utilize CD1a and Langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113 (2004) 701-708
115. Ide F., Iwase T., Saito I., Umemura S., and Nakajima T. Immunohistochemical and ultrastructural analysis of the proliferating cells in histiocytosis X. Cancer 53 (1984) 917-921
116. Isacke C.M., and Yarwood H. The hyaluronan receptor, CD44. Int. J. Biochem. Cell Biol. 34 (2002) 718-721
117. Ito T., Inaba M., Inaba K., Toki J., Sogo S., Iguchi T., Adachi Y., Yamaguchi K., Amakawa R., Valladeau J., Saeland S., Fukuhara S., and Ikehara S. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163 (1999) 1409-1419
118. Jaksits S., Kriehuber E., Charbonnier A.S., Rappersberger K., Stingl G., and Maurer D. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J. Immunol. 163 (1999) 4869-4877
119. Johansson A.-K., Sjostrand M., Tomaki M., Samulesson A.-M., and Lotvall J. Allergen stimulates bone marrow CD34+ cells to release IL-5 in vitro; a mechanism involved in eosinophilic inflammation?. Allergy 59 (2004) 1080-1086
120. In: Kaatsch P., Maaf H.G., and Michalis J. (Eds). Jahresbericht 1993 des Deutschen Kinderkrebregisters Vol.6 (1994), IMSD Johannes Gutenberg, Universitat Institut fur Medizinishe Statistik und Dokumentation, Mainz, Germany
121. Kannourakis G., and Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br. J. Cancer Suppl. 70 (1994) S37-S40
122. Kaplan G., Walsh G., Guido L.S., Meyn P., Burkhardt R.A., Abalos R.M., Barker J., Frindt P.A., Fajardo T.T., Celona R., and Cohn Z.A. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med. 175 (1992) 1717-1728
123. Kapsenberg M.L., Jansen H.M., Bos J.D., and Wierenga E.A. Role of type 1 and type 2 T helper cells in allergic diseases. Curr. Opin. Immunol. 4 (1992) 788
124. Kashihara M., Ueda M., Horiguchi Y., Furakawa F., Hanaoka M., and Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells. J. Invest. Dermatol. 87 (1986) 602
125. Kaya G., Rodriguez I., Jorcano J.L., Vassalli P., and Stamenkovic I. Cutaneous delayed-type hypersensitivity response is inhibited in transgenic mice with keratinocyte-specific CD44 expression defect. J. Invest. Dermatol. 113 (1999) 137-138
126. Kelley J. Cytokines of the lung. Am. Rev. Respir. Dis. 141 (1990) 765-788
127. Kishimoto T., Taga T., and Akira S. Cytokine signal transduction. Cell 76 (1994) 253-262
128. Knudson Jr. A.G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45 (1985) 1437-1443
129. Kobayashi M., Asano H., Fujita Y., and Hoshino T. Development of ATPase-positive, immature Langerhans cells in the fetal mouse epidermis and their maturation during the early postnatal period. Cell Tissue Res. 248 (1987) 315-322
130. Kobayashi Y., Matsumoto M., Kotani M., and Makino T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163 (1999) 5989-5993
131. Koch R.M., Roche N.S., Parks W.T., Ashcroft G.S., Letterio J.J., and Roberts A.B. Incisional wound healing in transforming growth factor-beta1 null mice. Wound Repair Regen. 8 (2000) 179-191
132. Koyama Y., Fukaya Y., Ueda H., Hachiya T., Hagiwara M., Hidaka H., and Marunouchi T. Expression of protein kinase C isoenzyme in human Langerhans cells. Acta. Derm. Venereol. 70 (1991) 502-505
133. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., and Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
134. Laman J.D., Leenen P.J., Annels N.E., Hogendoorn P.C., and Egeler R.M. Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol. 24 (2003) 190-196
135. Lappin M.B., Kimber I., and Norval M. The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 288 (1996) 109-121
136. Larregina A., Morelli A., Kolkowski E., and Fainbom L. Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short term culture. Immunology 87 (1996) 317-325
137. Larregina A.T., Morelli A.E., Spencer L.A., Logar A.J., Watkins S.C., Thomson A.W., and Falo Jr. L.D. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2 (2001) 1151-1158
138. Lebre M.C., Kalinski P., Das P.K., and Everts V. Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitors. Arch. Dermatol. Res. 291 (1999) 447-452
139. Lenz A., Heine M., Schuler G., and Romani N. Human and murine dermis contain dendritic cells. J. Clin. Invest. 92 (1993) 2587-2596
140. Leonard W.J. Type I cytokines and interferons and their receptors. In: Paul W.E. (Ed). "Fundamental Immunology" (2003), Lippincott, Williams & Wilkins, Philadelphia 702
141. Leung E.W., Vanek W., Abdelhaleem M., Freedman M.H., and Dror Y. The evolution of juvenile myelomonocytic leukemia in a female patient with paternally inherited neurofibromatosis type 1. J. Pediatr. Hematol. Oncol. 25 (2003) 145-147
142. Liao F., Rabin R.L., Smith C.S., Sharma G., Nutman T.B., and Farber J.M. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J. Immunol. 162 (1999) 186-194
143. Ludewig B., Graf D., Gelderblom H.R., Becker Y., Kroczek R.A., and Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25 (1995) 1943-1950
144. Ludewig B., Henn V., Schroder J.M., Graf D., and Kroczek R.A. Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. Eur. J. Immunol. 26 (1996) 3137-3143
145. Macatonia S.E., Knight S.C., Edwards A.J., Griffiths S., and Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166 (1987) 1654-1667
146. Maurer A.B., Ganser A., Buhl R., Seipelt G., Ottmann O.G., Mentzel U., Geissler R.G., and Hoelzer D. Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. Leukemia 7 (1993) 1728-1733
147. Mazzucchelli L., Blaser A., Kappeler A., Schärli P., Laissue J.A., Baggiolini M., and Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 104 (1999) R49-R54
148. McClain K.L., Cai Y.H., Hicks J., Peterson L.E., Yan X.T., Che S., and Ginsberg S.D. Expression profiling using human tissues in combination with RNA amplification and microarray analysis: Assessment of Langerhans cell histiocytosis. Amino Acids 28 (2005) 279-290
149. McKnight A.J., and Gordon S. The EGF-TM7 family: Unusual structures at the leukocyte surface. J. Leukoc. Biol. 63 (1998) 271-280
150. Merad M., Manz M.G., Karsunsky H., Wagers A., Peters W., Charo I., Weismann I.L., Cyster J.G., and Engleman E.G. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3 (2002) 1135-1141
151. Millonig G., Niederegger H., Rabl W., Hochleitner B.W., Hoefer D., Romani N., and Wick G. Network of vascular-associated dendritic cells in intima of healthy young individuals. Vasc. Biol. 21 (2001) 503-508
152. Mitsui H., Watanabe T., Saeki H., Mori K., Fujita H., Tada Y., Asahina A., Nakamura K., and Tamaki K. Differential expression and function of Toll-like receptors in Langerhans cells: Comparison with splenic dendritic cells. J. Invest. Dermatol. 122 (2004) 95-102
153. Miyauchi S., and Hashimoto K. Epidermal Langerhans cells undergo mitosis during the early recovery phase after ultraviolet-B irradiation. J. Invest. Dermatol. 88 (1989) 703-708
154. Miyauchi S., and Hashimoto K. Mitotic activities of normal epidermal Langerhans cells. J. Invest. Dermatol. 92 (1989) 120-121
155. Mollah Z.U., Aiba S., Nakagawa S., Mizuashi M., Ohtani T., Yoshino Y., and Tagami H. Interleukin-3 in cooperation with transforming growth factor beta induces granulocyte macrophage colony stimulating factor independent differentiation of human CD34+ hematopoietic progenitor cells into dendritic cells with features of Langerhans cells. J. Invest. Dermatol. 121 (2003) 1397-1401
156. Moore T.A., and Zlotnik A. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood 86 (1995) 1850-1860
157. Moretta A. Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat. Rev. Immunol. 2 (2002) 957-964
158. Moretta A. The dialogue between human natural killer cells and dendritic cells. Curr. Opin. Immunol. 17 (2005) 306-311
159. Moretta A., Bottino C., Mingari M.C., Biassoni R., and Moretta L. What is a natural killer cell?. Nat. Immunol. 3 (2002) 6-8
160. Most J., Spotl L., Mayr G., Gasser A., Sarti A., and Dierich M.P. Formation of multinucleated giant cells in vitro is dependent on the stage of monocyte to macrophage maturation. Blood 89 (1997) 662-671
161. Mummert D.I., Takashima A., and Mummert M.E. Langerhans cells in CD44-deficient mice emigrate from the epidermis but fail to reach the lymph nodes after hapten application. J. Invest. Dermatol. 122 (2004) 846-847
162. Murakami I., Gogusev J., Fournet J.C., Glorion C., and Jaubert F. Detection of molecular cytogenetic aberrations in Langerhans cell histiocytosis of bone. Hum. Pathol. 33 (2002) 555-560
163. Murphy G.F., Messadi D., Fonferko E., and Hancock W.W. Phenotypic transformation of macrophages to Langerhans cells in the skin. Am. J. Pathol. 123 (1986) 401-406
164. Nagata S., and Suda T. Fas and Fas ligand: lpr and lgd mutations. Immunol. Today 16 (1995) 39-43
165. Nakano H., Tamura T., Yoshimoto T., Yagita H., Miyasaka M., Butcher E.C., Nariuchi H., Kakiuchi T., and Matsuzawa A. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur. J. Immunol. 27 (1997) 212-215
166. Namba K., Nishio M., Mori K., Miyamoto N., Tsurudome M., Ito M., Kawano M., Uchida A., and Ito Y. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell Immunol. 213 (2001) 104-113
167. Nguyen T.T., Schwartz E.J., West R.B., Warnke R.A., Arber D.A., and Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am. J. Surg. Pathol. 29 (2005) 617-624
168. Nicholson H.S., Egeler R.M., and Nesbit M.E. "The Epidemiology of Langerhans Cell Histiocytosis." (1998), W. B. Saunders, Philadelphia
169. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., and Forster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
170. Okamoto H., Mizuno K., and Horio T. Monocyte-derived multinucleated giant cells and sarcoidosis. J. Dermatol. Sci. 31 (2003) 119-128
171. Ornvold K., Ralfkiaer E., and Carstensen H. Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis x). Virchows Arch. A Pathol. Anat. Histopathol. 416 (1990) 403-410
172. Parsonage G., Filer A.D., Haworth O., Nash G.B., Rainger G.E., Salmon M., and Buckley C.D. A stromal address code defined by fibroblasts. Trends Immunol. 26 (2005) 150-156
173. Peiser M., Grutzkau A., Wanner R., and Kolde G. CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells. J. Immunol. Methods 279 (2003) 41-53
174. Peiser M., Wanner R., and Kolde G. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking. J. Leukoc. Biol. 76 (2004) 616-622
175. Petersen B.L., Rengtved P., Bank M.I., and Carstensen H. High expression of markers of apoptosis in Langerhans cell histiocytosis. Histopathology 42 (2003) 186-193
176. Pilling D., Akbar A.N., Girdlestone J., Orteu C.H., Borthwick N.J., Amft N., Scheel-Toellner D., Buckley C.D., and Salmon M. Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29 (1999) 1041-1050
177. Porcelli S.A., and Modlin R.L. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17 (1999) 297-329
178. Price A.A., Cumberbatch M., Kimber I., and Ager A. 6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186 (1997) 1725-1735
179. Pulendran B., Banchereau J., Burkeholder S., Kraus E., Guinet E., Chalouni C., Caron D., Maliszewski C., Davoust J., Fay J., and Palucka K. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165 (2000) 566-572
180. Radeke H.H., von Wenckstern H., Stoidtner K., Sauer B., Hammer S., and Kleuser B. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J. Immunol. 174 (2005) 2778-2786
181. Rattis F.M., Peguet-Navarro J., Staquet M.J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., and Schmitt D. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur. J. Immunol. 26 (1996) 449-453
182. Ratzinger G., Baggers J., de Cos M.A., Yuan J., Dao T., Reagan J.L., Munz C., Heller G., and Young J.W. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J. Immunol. 173 (2004) 2780-2791
183. Ratzinger G., Stoitzner P., Ebner S., Lutz M.B., Layton G.T., Rainer C., Senior R.M., Shipley J.M., Fritsch P., Schuler G., and Romani N. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168 (2002) 4361-4371
184. Reams Jr. W.M., and Tompkins S.P. A developmental study of murine epidermal Langerhans cells. Dev. Biol. 31 (1973) 114-123
185. Reid C.D., Stackpoole A., Meager A., and Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol. 149 (1992) 2681-2688
186. Reis e Sousa C., Stahl P.D., and Austyn J.M. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178 (1993) 509-519
187. Reynolds N.J., Yi J.Y., Fisher G.J., Cooper K.D., Voorhees J.J., and Griffiths C.E. Down-regulation of Langerhans cell protein kinase C-isoenzyme expression in inflammatory and hyperplastic dermatoses. Br. J. Dermatol. 133 (1995) 157-167
188. Riedl E., Strobl H., Majdic O., and Knapp W. TGF-1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J. Immunol. 158 (1997) 1591-1597
189. Rivollier A., Mazzorana M., Tebib J., Piperno M., Aitsiselmi T., Rabourdin-Combe C., Jurdic P., and Servet-Delprat C. Immature dendritic cell transdifferentiation into osteoclasts: A novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104 (2004) 4029-4037
190. Rolland A., Guyon L., Gill M., Cai Y.H., Banchereau J., McClain K., and Palucka A.K. Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J. Immunol. 174 (2005) 3067-3071
191. Romani N., and Schuler G. The immunological properties of epidermal Langerhans cells as part of the dendritic cell system. Springer Semin. Immunopathol. 13 (1992) 265-279
192. Romani N., Schuler G., and Fritsch P. Ontogeny of Ia-positive and Thy-1-positive leukocytes of murine epidermis. J. Invest. Dermatol. 86 (1986) 129-133
193. Ross R., Raines E.W., and Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell 46 (1986) 155-169
194. Rosso D.A., Roy A., Zelazko M., and Braier J.L. Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis. Br. J. Haematol. 117 (2002) 54-58
195. Ruco L.P., Stoppacciaro A., Vitolo D., Uccini S., and Baroni C.D. Expression of adhesion molecules in Langerhans' cell histiocytosis. Histopathology 23 (1993) 29-37
196. Rumbley C.A., Sugaya H., Zekavat S.A., El Refaei M., Perrin P., and Philips S.M. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J. Immunol. 162 (1999) 1003-1009
197. Ruttledge M.H., Sarrazin J., Rangaratnam S., Phelan C.M., Twist E., Merel P., Delattre O., Thomas G., Nordenskjold M., Collins V.P., et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat. Genet. 6 (1994) 180-184
198. Santiago-Schwarz F., Coppock D.L., Hindenburg A.A., and Kern J. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84 (1994) 3054-3062
199. Savell Jr. V.H., Sherman T., Scheuermann R.H., Siddiqui A.M., and Margraf L.R. Bcl-2 expression in Langerhans' cell histiocytosis. Pediatr. Dev. Pathol. 1 (1998) 210-215
200. Scappaticci S., Danesino C., Rossi E., Klersy C., Fiori G.M., Clementi R., Russotto V.S., Bossi G., and Arico M. Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histocytosis. AIEOP-Istiocitosi Group. Br. J. Haematol. 111 (2000) 258-262
201. Schmid-Grendelmeier P., Altznauer F., Fischer B., Bizer C., Straumann A., and Menz G.E.A. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J. Immunol. 169 (2002) 1021-1027
202. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., and Mak T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90 (1997) 2217-2233
203. Schmitz L., and Favara B.L. Nosology and pathology of Langerhans cell histiocytosis. Hematol. Oncol. Clin. North Am. 12 (1998) 221-246
204. Schon-Hegrad M.A., Oliver J., McMenamin P.G., and Holt P.G. Studies on density, distribution, and surface phenotype of intraepithelial class II major histocompatability complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J. Exp. Med. 173 (1991) 1345-1356
205. Schouten B., Egeler R.M., Leenen P.J., Taminiau A.H., van den Broek L.J., and Hogendoorn P.C. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24 (2002) 727-732
206. Schultz C., Klouche M., Friedrichsdorf S., Richter N., Kroehnert B., and Bucsky P. Langerhans cell histiocytosis in children: Does soluble interleukin-2-receptor correlate with both disease extent and activity?. Med. Pediatr. Oncol. 31 (1998) 61-65
207. Schwarzenberger K., and Udey M.C. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106 (1996) 553-558
208. Schweizer J., and Marks F. A developmental study of the distribution and frequency of Langerhans cells in relation to formation of patterning in mouse tail epidermis. J. Invest. Dermatol. 69 (1977) 198-204
209. Scott S., Pandolfi F., and Kurnick J.T. Fibroblasts mediate T cell survival: A proposed mechanism for retention of primed T cells. J. Exp. Med. 172 (1990) 1873-1876
210. Shelley J.B., and Juhlin L. Langerhans' cells form a reticuloepithelial trap for external contact sensitizers. Nature 261 (1976) 46
211. Shortman K., and Caux C. Dendritic cell development: Multiple pathways to nature's adjuvants. Stem Cells 15 (1997) 409-419
212. Silberberg-Sinakin I., Thorbecke G.J., Baer R.L., Rosenthal S.A., and Berezowsky V. Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol. 25 (1976) 137-151
213. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
214. Strobl H., Riedl E., Scheinecker C., Bello-Fernandez C., Pickl W.F., Rappersberger K., Majdic O., and Knapp W. TGF-beta1 promotes in vitro development of dendritic cells from CD34+ hematopoietic progenitors. J. Immunol. 157 (1996) 1499-1507
215. Suss G., and Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183 (1996) 1789-1796
216. Swanson J.A., and Watts C. Macropinocytosis. Trends Cell. Biol. 5 (1995) 424-428
217. Takashima A., Xu S., Ariizumi K., and Bergstresser P.R. Establishment and characterization of antigen-presenting cell lines (XS series) derived from newborn mouse epidermis. Adv. Exp. Med. Biol. 378 (1995) 159-162
218. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., and Gordon S. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23 (2005) 901-944
219. Tazi A., Moreau J., Bergeron A., Dominique S., Hance A.J., and Soler P. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: Importance of the cytokine microenvironment. J. Immunol. 163 (1999) 3511-3515
220. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
221. Thomas R.M., Belsito D.V., Huang C., Chen L.Z., Ormsby I., Simmons W.J., Cowin P., Shaw J., Doetschman T., and Thorbecke G.J. Appearance of Langerhans cells in the epidermis of Tgfb1/ SCID mice: Paracrine and autocrine effects of transforming growth factor beta1 and beta2. J. Invest. Dermatol. 117 (2001) 1574-1580
222. Tigalonowa M., Bjerke J.R., and Matre R. Fc gamma-receptor as a functional marker on epidermal Langerhans' cells in situ. Acta. Derm. Venereol. 69 (1989) 477-481
223. Tohyama M., Shirakara Y., Yamasaki K., Sayama K., and Hashimoto K. Differentiated keratinocytes are responsible for TNF- regulated production of macrophage inflammatory protein 3/CCL20, a potent chemokine for Langerhans cells. J. Dermatol. Sci. 27 (2001) 130-139
224. Toraldo G., Roggia C., Qian W.P., Pacifici R., and Weitzmann M.N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 125-130
225. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47 (1989) 187-376
226. Tripp C.H., Chang-Rodriguez S., Stoitzner P., Holzmann S., Stossel H., Douillard P., Saeland S., Koch F., Elbe-Burger A., and Romani N. Ontogeny of Langerin/CD207 expression in the epidermis of mice. J. Invest. Dermatol. 122 (2004) 670-672
227. Turville S.G., Cameron P.U., Handley A., Lin G., Pöhlmann S., Doms R.W., and Cunningham A.L. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3 (2002) 975-983
228. Uebelhoer M., Bewig B., Kreipe H., Nowak D., Magnussen H., and Barth J. Modulation of fibroblast activity in histiocytosis X by platelet-derived growth factor. Chest 107 (1995) 701-705
229. Valladeau J., Dezutter-Dambuyant C., and Saeland S. Langerin/CD207 sheds light on formation of Birbeck granules and their possible function in Langerhans cells. Immunol. Res. 20 (2003) 93-107
230. Valladeau J., Ravel O., Dezutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., Duvert-Frances V., Vincent C., Schmitt D., Davoust J., Caux C., Lebecque S., and Saeland S. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 (2000) 71-81
231. Valladeau J., and Saeland S. Cutaneous dendritic cells. Semin. Immunol. 17 (2005) 273-283
232. Verdijk P., Dijkman R., Plasmeijer E.I., Mulder A.A., Zoutman W.H., Mieke Mommaas M.A., and Tensen C.P. A lack of Birbeck granules in Langerhans cells is associated with a naturally occurring point mutation in the human Langerin gene. J. Invest. Dermatol. 124 (2005) 714-717
233. Vitale M., Della Chiesa M., Carlomagno S., Romagnani C., Thiel A., Moretta L., and Moretta A. The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur. J. Immunol. 34 (2004) 1715-1722
234. Vogelstein B., Fearon E.R., Hamilton S.R., Preisinger A.C., Willard H.F., Michelson A.M., Riggs A.D., and Orkin S.H. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res. 47 (1987) 4806-4813
235. Wang B., Kondo S., Shivji G.M., Fujisawa H., Mak T.W., and Sauder D.N. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology 88 (1996) 284-288
236. Wang K., Scheel-Toellner D., Wong S.H., Craddock R., Caamano J., Akbar A.N., Salmon M., and Lord J.M. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J. Immunol. 171 (2003) 1035-1041
237. Wang M., Qin X., Mudgett J.S., Ferguson T.A., Senior R.M., and Welgus H.G. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. USA 96 (1999) 6885-6889
238. Wardlaw A.J. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. J. Allergy Clin. Immunol. 104 (1999) 917-926
239. Weintraub M., Bhatia K.G., Chandra R.S., Magrath I.T., and Ladisch S. p53 expression in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 20 (1998) 12-17
240. Weith A., Brodeur G.M., Bruns G.A., Matise T.C., Mischke D., Nizetic D., Seldin M.F., van Roy N., and Vance J. Report of the second international workshop on human chromosome 1 mapping 1995. Cytogenet. Cell Genet. 72 (1996) 114-144
241. Weitzmann M.N., Cenci S., Rifas L., Brown C., and Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 96 (2000) 1873-1878
242. Wierenga E.A., Bakkx B., Snoek M., Koenderman L., and Kapsenberg M.L. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood 82 (1993) 1471-1479
243. Willman C.L., Busque L., Griffith B.B., Favara B.E., McClain K.L., Duncan M.H., and Gilliland D.G. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N. Engl. J. Med. 331 (1994) 154-160
244. Xu S., Ariizumi K., Caceres-Dittmar G., Edelbaum D., Hashimoto K., Bergstresser P.R., and Takashima A. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J. Immunol. 154 (1995) 2697-2705
245. Yamagami S., Hamrah P., Miyamoto K., Miyazaki D., Dekaris I., Dawson T., Lu B., Gerard C., and Dana M.R. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1201-1207
246. Yan M., Penga J., Jabbara I.A., Liua X., Filgueirab L., Frazera I.H., and Thomas R. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology 324 (2004) 297-310
247. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Goto M., Mochizuki S.I., Tsuda E., Morinaga T., Udagawa N., Takahashi N., Suda T., and Higashio K. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25 (1999) 109-113
248. Yousem S.A., Colby T.V., Chen Y.Y., Chen W.G., and Weiss L.M. Pulmonary Langerhans' cell histiocytosis: Molecular analysis of clonality. Am. J. Surg. Pathol. 25 (2001) 630-636
249. Yu R.C., Chu C., Buluwela L., and Chu A.C. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 343 (1994) 767-768
250. Zhang Y., Harada A., Wang J.B., Zhang Y.Y., Hashimoto S., Naito M., and Matsushima K. Bifurcated dendritic cell differentiation in vitro from murine lineage phenotype-negative c-kit+ bone marrow hematopoietic progenitor cells. Blood 92 (1998) 118-128
251. Zhang Y., Zhang Y.Y., Ogata M., Chen P., Harada A., Hashimoto S., and Matsushima K. Transforming growth factor-1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway. Blood 93 (1999) 1208-1220
252. Zinkernagel R.M. Immunology taught by viruses. Science 271 (1996) 173-178